JP2023519101A5 - - Google Patents
Info
- Publication number
- JP2023519101A5 JP2023519101A5 JP2022548612A JP2022548612A JP2023519101A5 JP 2023519101 A5 JP2023519101 A5 JP 2023519101A5 JP 2022548612 A JP2022548612 A JP 2022548612A JP 2022548612 A JP2022548612 A JP 2022548612A JP 2023519101 A5 JP2023519101 A5 JP 2023519101A5
- Authority
- JP
- Japan
- Prior art keywords
- grna
- nucleic acid
- sequence
- exon
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062975636P | 2020-02-12 | 2020-02-12 | |
| US62/975,636 | 2020-02-12 | ||
| PCT/US2021/017942 WO2021163550A1 (en) | 2020-02-12 | 2021-02-12 | Haplotype-based treatment of rp1 associated retinal degenerations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023519101A JP2023519101A (ja) | 2023-05-10 |
| JP2023519101A5 true JP2023519101A5 (cg-RX-API-DMAC7.html) | 2024-02-21 |
Family
ID=77292955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548612A Pending JP2023519101A (ja) | 2020-02-12 | 2021-02-12 | Rp1関連網膜変性症のハプロタイプに基づく処置 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12129496B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4103238A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023519101A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115427568A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021219795A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021163550A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022216614B2 (en) | 2021-02-05 | 2026-03-05 | Christiana Care Gene Editing Institute, Inc. | Methods of and compositions for reducing gene expression and/or activity |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3023787A1 (de) | 1980-06-25 | 1982-01-21 | Studiengesellschaft Kohle mbH, 4330 Mülheim | Verfahren zur erhoehung der inkorporation und der expression von genetischem material in die kerne von intakten zellen mit hilfe von liposomen |
| JPS57124055A (en) | 1981-01-27 | 1982-08-02 | Toyota Motor Corp | Air-fuel ratio control device for engine |
| DE3681787D1 (de) | 1985-07-05 | 1991-11-07 | Whitehead Biomedical Inst | Expression von fremdem genetischem material in epithelzellen. |
| US4980286A (en) | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
| HK1008049A1 (en) | 1987-09-11 | 1999-04-30 | Whitehead Institute For Biomedical Research | Transduced fibroblasts and use therefor |
| ATE110108T1 (de) | 1987-12-11 | 1994-09-15 | Whitehead Biomedical Inst | Genetische modifizierung von endothelialen zellen. |
| DE68927996T2 (de) | 1988-02-05 | 1997-12-04 | Hughes Howard Med Inst | Modifizierte hepatozyten und deren anwendung |
| EP0452457B1 (en) | 1989-11-03 | 1997-08-20 | Vanderbilt University | Method of in vivo delivery of functioning foreign genes |
| DE69123981T3 (de) | 1990-10-31 | 2006-06-14 | Cell Genesys Inc | Nützliche retrovirale vektoren für die gentherapie |
| CN105408483A (zh) | 2013-03-15 | 2016-03-16 | 通用医疗公司 | 遗传和表观遗传调节蛋白至特定基因组基因座的rna引导的靶向 |
| HUE052676T2 (hu) | 2013-10-11 | 2021-05-28 | Massachusetts Eye & Ear Infirmary | Eljárások õsi vírusszekvenciák elõrejelzésére és alkalmazásaik |
| AU2016226077B2 (en) | 2015-03-03 | 2021-12-23 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases with altered PAM specificity |
| WO2017040348A1 (en) | 2015-08-28 | 2017-03-09 | The General Hospital Corporation | Engineered crispr-cas9 nucleases |
| US11566263B2 (en) * | 2016-08-02 | 2023-01-31 | Editas Medicine, Inc. | Compositions and methods for treating CEP290 associated disease |
| WO2018148246A1 (en) * | 2017-02-07 | 2018-08-16 | Massachusetts Institute Of Technology | Methods and compositions for rna-guided genetic circuits |
| WO2018195545A2 (en) | 2017-04-21 | 2018-10-25 | The General Hospital Corporation | Variants of cpf1 (cas12a) with altered pam specificity |
| US20210032612A1 (en) | 2018-02-22 | 2021-02-04 | Avellino Lab Usa, Inc. | CRISPR/Cas9 Systems, and Methods of Use Thereof |
| EP3768327A4 (en) * | 2018-03-23 | 2022-04-13 | The Trustees of Columbia University in the City of New York | GENE EDIT FOR AUTOSOMAL DOMINANT DISEASES |
| CA3094828A1 (en) * | 2018-03-23 | 2019-09-26 | Massachusetts Eye And Ear Infirmary | Crispr/cas9-mediated exon-skipping approach for ush2a-associated usher syndrome |
-
2021
- 2021-02-12 US US17/175,234 patent/US12129496B2/en active Active
- 2021-02-12 CN CN202180027183.4A patent/CN115427568A/zh active Pending
- 2021-02-12 JP JP2022548612A patent/JP2023519101A/ja active Pending
- 2021-02-12 WO PCT/US2021/017942 patent/WO2021163550A1/en not_active Ceased
- 2021-02-12 AU AU2021219795A patent/AU2021219795A1/en active Pending
- 2021-02-12 EP EP21753483.3A patent/EP4103238A4/en active Pending
-
2024
- 2024-09-19 US US18/890,708 patent/US20250115887A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250235556A1 (en) | Gene therapy for autosomal dominant diseases | |
| EP3322297B1 (en) | Delivery methods and compositions for nuclease-mediated genome engineering | |
| AU2014364051B2 (en) | Methods and compositions for treating hemophilia | |
| RU2650819C2 (ru) | Способы и композиции для опосредованной нуклеазой направленной интеграции трансгенов | |
| EP4186921A1 (en) | Gene editing for autosomal dominant diseases | |
| JP7012650B2 (ja) | Dna結合ドメインと切断ドメインとを連結するための組成物 | |
| JP2020120690A (ja) | 遺伝的状態の処置のための方法および組成物 | |
| WO2018162702A1 (en) | Nuclease fusions for enhancing genome editing by homology-directed transgene integration | |
| EP3867375A1 (en) | Genome editing methods and constructs | |
| Carvalho et al. | Gene therapy for inherited retinal diseases: exploiting new tools in genome editing and nanotechnology | |
| Epstein et al. | Combining engineered nucleases with adeno-associated viral vectors for therapeutic gene editing | |
| US20210054372A1 (en) | Methods of inactivating gene editing machineries | |
| JP2025175283A (ja) | Amdの処置のためのhtra1調節 | |
| US20240132881A1 (en) | Differential knockout of an allele of a heterozygous bestrophin 1 gene | |
| US20220307057A1 (en) | Crispr compositions and methods for promoting gene editing of gata2 | |
| HK40075787A (en) | Gene therapy for autosomal dominant diseases | |
| US12031149B2 (en) | Compositions and methods for promoting gene editing of CXCR4 gene | |
| JP2025506403A5 (cg-RX-API-DMAC7.html) | ||
| WO2026032020A1 (zh) | Aav介导的rpgr x连锁视网膜变性的基因编辑治疗方法 | |
| WO2026036033A1 (en) | Products and methods for treatment of autosomal dominant genetic diseases involving diversified disease causing mutations | |
| HK40069063B (en) | Methods and compositions for treating thalassemia or sickle cell disease | |
| WO2026088097A1 (en) | Mutation-independent genome editing | |
| HK1251615B (en) | Gene therapy for autosomal dominant diseases | |
| US20230173107A1 (en) | Guide rna that targets a mutant human inosine monophosphate deydrogenase i allele |